The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
about
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
description
scientific article published on 01 April 2006
@en
name
The influences of hyperprolact ...... effects of cabergoline therapy
@en
type
label
The influences of hyperprolact ...... effects of cabergoline therapy
@en
prefLabel
The influences of hyperprolact ...... effects of cabergoline therapy
@en
P2093
P1476
The influences of hyperprolact ...... effects of cabergoline therapy
@en
P2093
Fritz Maingrette
Geneviève Renier
Marie-Claude Beauchamp
Omar Serri
P304
P356
10.1111/J.1365-2265.2006.02469.X
P577
2006-04-01T00:00:00Z